Medical News

RSS

CAR T therapy extends its reach beyond oncology

Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers.

23 Nov 2022

MiRNAs can be used as a biomarker to predict disease recurrence and mortality in breast cancer patients

Researchers at University of Galway have determined that biomarkers known as microRNAs can help predict which patients with breast cancer are likely to face a recurrence of the disease and death.

23 Nov 2022

Researchers find a way to predict the course of the disease in ALS patients

By measuring immune cells in the cerebrospinal fluid when diagnosing ALS, it is possible to predict how fast the disease may progress according to a study from Karolinska Institutet published in Nature Communications.

23 Nov 2022

Maternal obesity during pregnancy causes metabolic perturbations in offspring's liver and skeletal muscle

A recent study in The FASEB Journal has identified metabolic perturbations in the liver and skeletal muscle of young nonhuman primates on normal diets whose mothers were obese during pregnancy.

23 Nov 2022

Study explores link between dynamic changes in metabolic syndrome and risk of gout

In a study published in Arthritis & Rheumatology that included nearly 1.3 million men aged 20–39 years who participated in three serial health check-ups at two-year intervals, men with metabolic syndrome (MetS) and those who developed MetS - especially those with the MetS components of elevated triglycerides and abdominal obesity - had higher risks of developing gout.

23 Nov 2022

Study identifies enlarged perivascular spaces in the brains of migraine sufferers

For the first time, a new study has identified enlarged perivascular spaces in the brains of migraine sufferers. Results of the study will be presented next week at the annual meeting of the Radiological Society of North America.

23 Nov 2022

Can SARS-CoV-2 be inactivated by resonance caused by sound waves at the ultrasound frequency?

Researchers performed in vitro experiments to test the ability of different frequencies of ultrasound to inactivate SARS-CoV-2.

23 Nov 2022

New research could be the first step in better targeting breast cancer treatment

Researchers have identified a protein that, when present in high amounts in breast cancer tumors, is an indicator of whether DNA-damaging therapies will work or not.

23 Nov 2022

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

A new study presents evidence suggestive of restored or increased efficacy from changing the formulation of COVID-19 vaccines to a bivalent one.

23 Nov 2022

Study suggests the behavior of an emergent SARS-CoV-2 variant may be sensitive to the immunologic and demographic context of its location

Researchers characterized the heterogeneity in the speed, magnitude, and timing of 13 SARS-CoV-2 variant transitions/waves.

23 Nov 2022

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), today announced they had entered into a formal collaboration.

From Sartorius 23 Nov 2022

Low-calorie sweetener does not seem to increase cancer risk in US adults

A recent study claims that the intake of low-calorie sweetener sweeteners does not increase the risk of cancer-related death. However, it may increase the risk of obesity and diabetes.

23 Nov 2022

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team.

From The Native Antigen Company 23 Nov 2022

The stability of SARS-CoV-2 variants in aerosols and on high density polyethylene

Researchers showed that some SARS-CoV-2 variants of concern exhibit greater surface and aerosol stability than the ancestral strain.

23 Nov 2022

New consultation focuses on the increasing risk of antibiotic-resistant infections

The increasing risk to patients of superbugs resistant to existing medicines will be the focus of a new consultation launched today [Wednesday 23].

23 Nov 2022

Over 440 SCI articles published! BGI’s cancer genetics and cell research fuels innovation

BGI has currently published over 440 SCI (Science Citation Index) papers in the field of cancer research, with a cumulative impact factor of over 4,000 points.

From BGI Genomics 23 Nov 2022

Optibrium appoints Ian Smith as Chief Technology Officer

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of Ian Smith as Chief Technology Officer (CTO), the latest in a number of senior-level hires for the Company.

From Optibrium Ltd. 23 Nov 2022

How did population immunity against SARS-CoV-2 infection and subsequent severe disease change between December 2021 and November 2022?

Researchers explored the alterations in population immunity against SARS-CoV-2 Omicron variant infection and severe disease.

23 Nov 2022

The safety and immunogenicity of a fourth dose of NVX-CoV2373

Researchers assessed the immunogenicity and safety of a fourth homologous boost dose of a recombinant SARS-CoV-2 spike protein vaccine called NVX-CoV2373.

23 Nov 2022

Study shows clear shifts in SARS-CoV-2 mutational spectrum during evolution

Researchers examined whether the mutational process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) itself has changed during the evolution of SARS-CoV-2.

23 Nov 2022

Medical News

CAR T therapy extends its reach beyond oncology

MiRNAs can be used as a biomarker to predict disease recurrence and mortality in breast cancer patients

Researchers find a way to predict the course of the disease in ALS patients

Maternal obesity during pregnancy causes metabolic perturbations in offspring's liver and skeletal muscle

Study explores link between dynamic changes in metabolic syndrome and risk of gout

Study identifies enlarged perivascular spaces in the brains of migraine sufferers

Can SARS-CoV-2 be inactivated by resonance caused by sound waves at the ultrasound frequency?

New research could be the first step in better targeting breast cancer treatment

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

Study suggests the behavior of an emergent SARS-CoV-2 variant may be sensitive to the immunologic and demographic context of its location

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Low-calorie sweetener does not seem to increase cancer risk in US adults

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The stability of SARS-CoV-2 variants in aerosols and on high density polyethylene

New consultation focuses on the increasing risk of antibiotic-resistant infections

Over 440 SCI articles published! BGI’s cancer genetics and cell research fuels innovation

Optibrium appoints Ian Smith as Chief Technology Officer

How did population immunity against SARS-CoV-2 infection and subsequent severe disease change between December 2021 and November 2022?

The safety and immunogenicity of a fourth dose of NVX-CoV2373

Study shows clear shifts in SARS-CoV-2 mutational spectrum during evolution

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News